Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)
Trial details
- Registry ID
- NCT05764239
- Drugs studied
- SYNB1934v1
TrialRedline tracks 1 clinical trial sponsored by Synlogic: 1 Phase 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)NCT05764239 | SYNB1934v1 | Terminated | 2024-03-15Actual |
Names as written in the registry records.